393 related articles for article (PubMed ID: 29172109)
1. The oral glucose test predicts laminitis risk in ponies fed a diet high in nonstructural carbohydrates.
Meier AD; de Laat MA; Reiche DB; Pollitt CC; Walsh DM; McGree JM; Sillence MN
Domest Anim Endocrinol; 2018 Apr; 63():1-9. PubMed ID: 29172109
[TBL] [Abstract][Full Text] [Related]
2. The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies.
Meier A; Reiche D; de Laat M; Pollitt C; Walsh D; Sillence M
PLoS One; 2018; 13(9):e0203655. PubMed ID: 30212530
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1, insulin-like growth factor-1, and adiponectin in insulin-dysregulated ponies: effects of feeding a high nonstructural carbohydrate diet and association with prospective laminitis.
Meier AD; de Laat MA; Reiche DB; Sillence MN
Domest Anim Endocrinol; 2020 Apr; 71():106397. PubMed ID: 31812879
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profile distinguishes laminitis-susceptible and -resistant ponies before and after feeding a high sugar diet.
Delarocque J; Reiche DB; Meier AD; Warnken T; Feige K; Sillence MN
BMC Vet Res; 2021 Jan; 17(1):56. PubMed ID: 33509165
[TBL] [Abstract][Full Text] [Related]
5. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
Karikoski NP; Patterson-Kane JC; Singer ER; McFarlane D; McGowan CM
Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.
de Laat MA; Sillence MN; Reiche DB
J Vet Intern Med; 2019 May; 33(3):1456-1463. PubMed ID: 30697823
[TBL] [Abstract][Full Text] [Related]
7. Association between hyperinsulinaemia and laminitis severity at the time of pituitary pars intermedia dysfunction diagnosis.
Tadros EM; Fowlie JG; Refsal KR; Marteniuk J; Schott HC
Equine Vet J; 2019 Jan; 51(1):52-56. PubMed ID: 29761574
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction.
Horn R; Bamford NJ; Afonso T; Sutherland M; Buckerfield J; Tan RHH; Secombe CJ; Stewart AJ; Bertin FR
Equine Vet J; 2019 Jul; 51(4):440-445. PubMed ID: 30417404
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.
Donaldson MT; Jorgensen AJ; Beech J
J Am Vet Med Assoc; 2004 Apr; 224(7):1123-7. PubMed ID: 15074858
[TBL] [Abstract][Full Text] [Related]
10. Equine laminitis: ultrastructural lesions detected in ponies following hyperinsulinaemia.
Nourian AR; Asplin KE; McGowan CM; Sillence MN; Pollitt CC
Equine Vet J; 2009 Sep; 41(7):671-7. PubMed ID: 19927586
[TBL] [Abstract][Full Text] [Related]
11. Effect of dietary fructans and dexamethasone administration on the insulin response of ponies predisposed to laminitis.
Bailey SR; Menzies-Gow NJ; Harris PA; Habershon-Butcher JL; Crawford C; Berhane Y; Boston RC; Elliott J
J Am Vet Med Assoc; 2007 Nov; 231(9):1365-73. PubMed ID: 17975996
[TBL] [Abstract][Full Text] [Related]
12. Plasma fructosamine concentrations in horses with pituitary pars intermedia dysfunction with and without laminitis.
Knowles EJ; Menzies-Gow NJ; Mair TS
Equine Vet J; 2014 Mar; 46(2):249-51. PubMed ID: 23663105
[TBL] [Abstract][Full Text] [Related]
13. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies.
Asplin KE; Sillence MN; Pollitt CC; McGowan CM
Vet J; 2007 Nov; 174(3):530-5. PubMed ID: 17719811
[TBL] [Abstract][Full Text] [Related]
14. BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction.
Menzies-Gow NJ; Banse HE; Duff A; Hart N; Ireland JL; Knowles EJ; McFarlane D; Rendle D
Equine Vet J; 2024 Mar; 56(2):220-242. PubMed ID: 37795557
[TBL] [Abstract][Full Text] [Related]
15. Effect of feeding glucose, fructose, and inulin on blood glucose and insulin concentrations in normal ponies and those predisposed to laminitis.
Borer KE; Bailey SR; Menzies-Gow NJ; Harris PA; Elliott J
J Anim Sci; 2012 Sep; 90(9):3003-11. PubMed ID: 22966077
[TBL] [Abstract][Full Text] [Related]
16. The effect of different grazing conditions on the insulin and incretin response to the oral glucose test in ponies.
Fitzgerald DM; Pollitt CC; Walsh DM; Sillence MN; de Laat MA
BMC Vet Res; 2019 Oct; 15(1):345. PubMed ID: 31619223
[TBL] [Abstract][Full Text] [Related]
17. Does oral prednisolone treatment increase the incidence of acute laminitis?
Jordan VJ; Ireland JL; Rendle DI
Equine Vet J; 2017 Jan; 49(1):19-25. PubMed ID: 26713748
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.
de Laat MA; Reiche DB; Sillence MN; McGree JM
J Vet Intern Med; 2019 May; 33(3):1473-1482. PubMed ID: 30972832
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital.
Karikoski NP; Horn I; McGowan TW; McGowan CM
Domest Anim Endocrinol; 2011 Oct; 41(3):111-7. PubMed ID: 21696910
[TBL] [Abstract][Full Text] [Related]
20. Seasonal and annual influence on insulin and cortisol results from overnight dexamethasone suppression tests in normal ponies and ponies predisposed to laminitis.
Borer-Weir KE; Menzies-Gow NJ; Bailey SR; Harris PA; Elliott J
Equine Vet J; 2013 Nov; 45(6):688-93. PubMed ID: 23521139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
